Core Insights - NU Skin Enterprises Inc. (NUS) reported Q3 2025 revenue of $364.2 million, adjusted net income of $17.1 million, and adjusted EPS of $0.34, which were below revenue estimates but above EPS estimates [1][7] - The company achieved a gross margin of 70.5% and reduced selling expenses to 35.8% company-wide, indicating effective cost management [1][7] - Management noted double-digit growth in Latin America and improvements across several segments, attributing EPS performance to execution and efficiency despite a challenging macro environment [1][7] Financial Performance - Revenue: $364.2 million, compared to estimates of $374.2 million [1][7] - Adjusted Net Income: $17.1 million, exceeding estimates of $14.7 million [1][7] - Adjusted EPS: $0.34, higher than the estimated $0.30 [1][7] - Gross Margin: 70.5% [1][7] - Selling Expense: 35.8% company-wide, 41.7% within the core business [1][7] Strategic Initiatives - Management remains focused on strategic initiatives despite weaker than expected top-line results [1][7] - Rhyz segment generated $51.6 million in revenue, with $47.6 million from Manufacturing and $4.0 million from Rhyz Other [1][7] - Upcoming product launches include Prysm iO limited preview in late Q4 2025 and pre-market activities in India ahead of a 2026 launch [7] Cash Position and Guidance - Cash reserves stood at $251.7 million [7] - Management has narrowed Q4 and full-year 2025 guidance with a continued focus on maintaining margins [7]